Kirsten van Bockstaele

Chief Financial Officer at Sequana Medical NV

Kirsten van Bockstaele

Kirsten van Bockstaele

Chief Financial Officer at Sequana Medical NV

Overview
Career Highlights

Sequana Medical AG
Sequana Medical NV
Arseus

RelSci Relationships

226

Birthday

1975

Age

46

Relationships
RelSci Relationships are individuals Kirsten van Bockstaele likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chief Executive Officer & Executive Director at Sequana Medical NV

Relationship likelihood: Strong

Chief Commercial Officer at Sequana Medical AG

Relationship likelihood: Strong

Co-Founder Managing Director at LSP Management Group BV

Relationship likelihood: Strong

Chief Commercial Officer at Sequana Medical AG

Relationship likelihood: Strong

Consulting Chief Medical Officer at Sequana Medical AG

Relationship likelihood: Strong

Global Vice President-Engineering & Manufacturing at Sequana Medical NV

Relationship likelihood: Strong

Founder at Neomed Management AS

Relationship likelihood: Strong

Director at Amal Therapeutics SA

Relationship likelihood: Strong

Global Vice President-Quality Management & Regulatory Affairs at Sequana Medical NV

Relationship likelihood: Strong

Former Founder, President & Chief Executive Officer at Sequana Medical AG

Relationship likelihood: Strong

Paths to Kirsten van Bockstaele
Potential Connections via
Relationship Science
You
Kirsten van Bockstaele
Chief Financial Officer at Sequana Medical NV
Education

UAntwerpen The University of Antwerp (Universiteit Antwerpen) is a young and dynamic Belgian university. It is characterised by its high standards in education, internationally competitive research and entrepreneurial approach. It was founded in 2003 after the merger of the three universities of Antwerp. The university's roots go back to 1852. The University of Antwerp has 9 faculties and several autonomous, faculty-like institutes. Doctoral programmes are available in all faculties, with more than 20,109 students (+1,479 PhD students) registered. In total the university has over 4.987 staff members. The University of Antwerp hosts 5 centres of excellence Nanostructures, Molecular Neurogenetics, Environmental Studies, Social Policy, Evaluation of Vaccination Education is student-centred and competency-based. Students are stimulated to develop into independently minded people who are capable of thinking analytically. The University of Antwerp has adopted the bachelor-master structure. It offers 3-year Bachelor programmes (180 ECTS credits) and 1-year or 2-year Master programmes (60 or 120 ECTS credits). The university is part of the Antwerp University Association (AUHA), a regional association with the university and 3university colleges for professional education.

Career History
Head-Treasury
Prior

Fagron NV engages in the development, marketing, and distribution of healthcare products and services. It operates through the following segments: Fagron Specialty Pharma Services (FSPS); Fagron Trademarks (FTM); Fagron Essentials (FE); and HL Technology. The FSPS segment refers to all personalized medication that is prepared in sterile and non-sterile compounding facilities in Europe, the United States, Colombia and South Africa. The FTM segment encompasses the innovative concepts, vehicles and formulations developed by Fagron, often in close cooperation with prescribers, pharmacies and universities. The FE segment relates to all pharmaceutical raw materials, equipment and supplies a pharmacist needs to prepare medication in its own pharmacy. The HL Technology segment is responsible for the development and production of precision components and orthopedic tools for the dental and medical industry. The company was founded in 1990 and is headquartered in Nazareth, Belgium.

Chief Financial Officer
2018 - Current

Sequana Medical AG operates as a medical device company. It specializes in the production and design of implantable pump systems to manage fluid balance within the body. The firm offers the Alfapump system, its proprietary solution to manage and remove ascites, which can occur as a symptom of liver disease, cancer, or congestive heart failure and its focus areas encompass clinical research, product innovation, and technology development. The company was founded by Noel L. Johnson in 2000 and is headquartered in Zurich, Switzerland.

Financial Controller
Prior

Omega Pharma NV engages in the manufacture and distribution of pharmaceutical products. It offers prescription medicines, health products, and cosmetics. The company was founded by Marc Coucke in 1987 and is headquartered in Nazareth, Belgium.

Other Affiliations

Kirsten van Bockstaele is affiliated with Fagron NV, Sequana Medical AG, Omega Pharma NV, Arseus, Sequana Medical NV

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Kirsten van Bockstaele. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Kirsten van Bockstaele's profile does not indicate a business or promotional relationship of any kind between RelSci and Kirsten van Bockstaele.